Behind the deal: Two Orlando biz owners share thoughts on being acquired and landing equity

SOURCE:  Orlando Business Journal  By Matthew Richardson  – Staff writer, Orlando Business Journal Orlando Business Journal zeroed in on two M&A deals in Central Florida, talking to the top local executives to get insights on what led to the decision to sell their companies — or a majority stake in it — and more: Josh Brown, founder and CEO, PowerDMS What led to the decision to form a partnership with Frontier Capital? We were about three years … Continue reading

People Are Leaving Silicon Valley and Orlando Might Be the Next Hot Spot

SOURCE: Inc. By: Jeff Barrett CEO, Barrett Digital Affordability, tech talent pools and access to capital top the list. It costs $2000 to rent a U-Haul in San Francisco. Rent one anywhere else and it’s roughly $100. This year the Bay Area will lose more people than any other region in the country. The reason is a variety of factors; affordability, access to opportunity and technology making it increasingly easier to work from anywhere. … Continue reading

Ballast Point Ventures Announces Majority Recapitalization of PowerDMS

Ballast Point Ventures III, LP (“BPV”) is pleased to announce that Frontier Capital has led a majority recapitalization of its portfolio company PowerDMS, an Orlando-based policy management software company. BPV invested in PowerDMS in 2014 to help the Company grow its sales and marketing team and further enhance its technology platform by offering new features to its customer base. Founded in 2001 by Chief Executive Officer Josh Brown, PowerDMS offers … Continue reading

MolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with Tasigna

SOURCE: MolecularMD Portland, Oregon and Cambridge, Massachusetts – December 22, 2017 MolecularMD Corporation, a  diagnostics company that enables the development and commercialization of precision medicines in oncology, announced today the FDA authorization of the MRDx® BCR-ABL Test as a companion diagnostic. The MRDx Test is indicated as an aid in identifying Philadelphia chromosome positive (Ph+) Chronic Myeloid Leukemia (CML) patients in the chronic phase being treated with Tasigna®* (nilotinib) capsules who may … Continue reading

Fast-growing Tampa digital firm snares $4 million local venture investment

Ballast Point Ventures has invested in Symphonic Distribution Inc. The $4 million is the first outside capital invested in Symphonic, based in Tampa and one of the largest independent music companies in the industry. Symphonic, which partners with Apple Music, Spotify, Amazon, Pandora and others, provides new and established record labels and individual musicians with digital music distribution tools that allow content creators to quickly and cost effectively distribute their music … Continue reading

Ballast Point Ventures Announces Successful Exit From TicketBiscuit

Tampa, FL – October 30, 2017 Ballast Point Ventures III, LP (“BPV”) is pleased to announce that it has successfully exited its growth equity investment in TicketBiscuit, a Birmingham-based online ticketing and event platform, through an acquisition by eTix. BPV invested in TicketBiscuit to help the Company grow its salesforce, bolster marketing efforts, and develop additional technology products. Founded in 2001 by Chief Executive Officer, Jeff Gale, TicketBiscuit has a rich history of … Continue reading

MeYou Health Names New CEO, Raises New Capital, and Enters a New Market

SOURCE: PRWEB With a new CEO and additional equity financing to optimize wellness program delivery for small and midsize employers, MeYou Health is ready to become the first provider of a wellness software-as-a-service (SaaS) solution in the SMB market. Boston, MA. (PRWEB) September 27, 2017 MeYou Health (MYH) today announced that Trapper Markelz, current President and Chief Operations Officer, has been named Chief Executive Officer of the Company. MYH has also … Continue reading

MolecularMD Announces Partnership with Indica Labs

SOURCE: StockGuru.com PORTLAND, Ore. and CAMBRIDGE, Mass., Sept. 28, 2017 (GLOBE NEWSWIRE) — MolecularMD, a provider of molecular and tissue-based clinical trial assays and diagnostics for oncology based drug development programs, has announced a partnership agreement with Indica Labs, a leader in digital pathology imaging tools and services. The collaboration between the companies leverages MolecularMD’s diagnostic clinical testing solutions with Indica Labs’ digital biomarker analysis services to enable an efficient transition of pre-clinical research to the diagnostic setting and deployment … Continue reading

TissueTech, Inc. Names John Arnott, Industry Executive, to Board of Directors

SOURCE: TissueTech, Inc. Arnott brings experience in a wide range of global healthcare MIAMI – August 3, 2017 – TissueTech Inc. announced today that it has named John Arnott to its Board of Directors. Mr. Arnott was most recently Operating Partner and Executive Chairman of multiple portfolio companies for The Riverside Company, one of largest and oldest global private equity firms. Mr. Arnott’s career in healthcare dates back four decades … Continue reading

TissueTech, Inc. Names Dr. Herbert B. Slade as Chief Medical Officer

SOURCE: TissueTech, Inc. MIAMI – August 1, 2017 – TissueTech, Inc. announced today that Herbert B. Slade, MD, has been named the company’s Chief Medical Officer (CMO). Dr. Slade, who will lead the execution of TissueTech’s clinical research strategies and be the primary liaison for medical affairs, has more than 25 years of healthcare industry-based experience, most recently at Smith & Nephew plc, where he was CMO and Senior Vice President … Continue reading

© 2018 Ballast Point Ventures. All rights reserved.